Pittsburgh Zantac Cancer Attorney | SMT Legal

Pittsburgh Zantac Cancer Attorneys

Over the last year, it has been discovered that Zantac could cause cancer due to high levels of a known carcinogenic material found within the product. The US Food and Drug Administration (FDA) has investigated this product and recently announced a recall of both prescription and over-the-counter Zantac and other ranitidine products.

The team at SMT Legal is here to help if you or loved one have taken Zantac and have subsequently gotten cancer. Our Pittsburgh Zantac cancer attorneys are ready to investigate your case and work to secure any compensation you may be entitled to.


We don’t get paid unless you get paid.
Contact us today for a free case evaluation.

call : 412-765-3345
Pittsburgh Zantac Cancer

What is Zantac?

Zantac is arguably the most popular prescription and over-the-counter medication used to treat a number of conditions, including acid reflux and heartburn, as well as other stomach, throat, and gastrointestinal conditions. Chemically known as ranitidine hydrochloride, Zantac has also been used in conjunction with other medications to treat allergies.

Dosages of Zantac typically range from 75 to 150-milligram tablets, though there are also 300 mg tablets that can be taken one time a day.

Get a Free Case

    * Fields are required

    Accept Disclaimer and Privacy Terms.

    Every case has a different dimension let's work together!
    For a free case evaluation
    call : 412-765-3345

    Does Zantac cause cancer?

    The US FDA has announced on April 1, 2020, that they are requesting manufacturers of Zantac and all generic ranitidine drugs to remove the medications from the market immediately. The FDA has issued this order after an ongoing investigation into whether or not ranitidine contains unsafe levels of N-nitrosodimethylamine (NDMA), which has been classified as a cancer-causing carcinogen.

    Testing has indicated that Zantac 150 mg tablets could contain up to 2,500,000 nanograms (ng) of NDMA. The FDA has set a daily safe limit of NDMA at 96 ng.

    Has a recall been issued for Zantac?

    Major pharmaceutical companies removed prescription and over-the-counter Zantac from their shelves last year after testing indicated unsafe levels of NDMA. The FDA, in their recent recall request, said that the impurity of NDMA in some ranitidine products increases over time and when stored at higher than room temperatures. As a result of this removal request from the FDA, Zantac and other ranitidine products will not be available for new or existing prescriptions or over-the-counter use in the US.

    The FDA has asked all consumers who currently have prescriptions or OTC versions of Zantac or other ranitidine products to stop taking them and dispose of the product immediately. Patients should speak to their health care providers about alternatives to these medications.

    What kind of compensation is available for these cases?

    If you or somebody you care about has been diagnosed with cancer and you believe that Zantac is the reason for the diagnosis, speak to a medical malpractice attorney immediately. At SMT Legal, we are going to thoroughly investigate your case in order to secure any compensation you are entitled to. This can include:

    • Cost of any medical bills related to the cancer
    • Recovery of income lost if you are unable to work
    • Pain and suffering damages
    • Loss of enjoyment of life damages
    • Possible punitive damages against Sanofi, the Zantac manufacturer

    When you need a Pittsburgh Zantac cancer attorney, you can contact us for a free consultation by clicking here or calling 1-888-976-2529.

    Tell Us Your Stories and Ask Us Your Questions

    Call 412-765-3345 for a free case evaluation. Our attorneys are available by phone, email or in-person.

    SMT Legal attorneys believe in aggressively representing our clients while maintaining the personal compassion needed when counseling clients through difficult situations and navigating a complex legal system. Contact us today.

    shape icon
    Our awards